×
S&P 500   3,785.38 (-0.88%)
DOW   30,775.43 (-0.82%)
QQQ   280.28 (-1.24%)
AAPL   136.72 (-1.80%)
MSFT   256.83 (-1.32%)
META   161.25 (-1.64%)
GOOGL   2,179.26 (-2.45%)
AMZN   106.21 (-2.49%)
TSLA   673.42 (-1.76%)
NVDA   151.59 (-2.46%)
NIO   21.72 (-0.64%)
BABA   113.68 (-2.03%)
AMD   76.47 (-1.95%)
MU   55.28 (-1.32%)
CGC   2.85 (-18.57%)
T   20.96 (+0.05%)
GE   63.67 (-0.03%)
F   11.13 (-3.39%)
DIS   94.40 (-1.31%)
AMC   13.55 (-0.73%)
PFE   52.43 (+2.93%)
PYPL   69.84 (-2.28%)
NFLX   174.87 (-1.96%)
S&P 500   3,785.38 (-0.88%)
DOW   30,775.43 (-0.82%)
QQQ   280.28 (-1.24%)
AAPL   136.72 (-1.80%)
MSFT   256.83 (-1.32%)
META   161.25 (-1.64%)
GOOGL   2,179.26 (-2.45%)
AMZN   106.21 (-2.49%)
TSLA   673.42 (-1.76%)
NVDA   151.59 (-2.46%)
NIO   21.72 (-0.64%)
BABA   113.68 (-2.03%)
AMD   76.47 (-1.95%)
MU   55.28 (-1.32%)
CGC   2.85 (-18.57%)
T   20.96 (+0.05%)
GE   63.67 (-0.03%)
F   11.13 (-3.39%)
DIS   94.40 (-1.31%)
AMC   13.55 (-0.73%)
PFE   52.43 (+2.93%)
PYPL   69.84 (-2.28%)
NFLX   174.87 (-1.96%)
S&P 500   3,785.38 (-0.88%)
DOW   30,775.43 (-0.82%)
QQQ   280.28 (-1.24%)
AAPL   136.72 (-1.80%)
MSFT   256.83 (-1.32%)
META   161.25 (-1.64%)
GOOGL   2,179.26 (-2.45%)
AMZN   106.21 (-2.49%)
TSLA   673.42 (-1.76%)
NVDA   151.59 (-2.46%)
NIO   21.72 (-0.64%)
BABA   113.68 (-2.03%)
AMD   76.47 (-1.95%)
MU   55.28 (-1.32%)
CGC   2.85 (-18.57%)
T   20.96 (+0.05%)
GE   63.67 (-0.03%)
F   11.13 (-3.39%)
DIS   94.40 (-1.31%)
AMC   13.55 (-0.73%)
PFE   52.43 (+2.93%)
PYPL   69.84 (-2.28%)
NFLX   174.87 (-1.96%)
S&P 500   3,785.38 (-0.88%)
DOW   30,775.43 (-0.82%)
QQQ   280.28 (-1.24%)
AAPL   136.72 (-1.80%)
MSFT   256.83 (-1.32%)
META   161.25 (-1.64%)
GOOGL   2,179.26 (-2.45%)
AMZN   106.21 (-2.49%)
TSLA   673.42 (-1.76%)
NVDA   151.59 (-2.46%)
NIO   21.72 (-0.64%)
BABA   113.68 (-2.03%)
AMD   76.47 (-1.95%)
MU   55.28 (-1.32%)
CGC   2.85 (-18.57%)
T   20.96 (+0.05%)
GE   63.67 (-0.03%)
F   11.13 (-3.39%)
DIS   94.40 (-1.31%)
AMC   13.55 (-0.73%)
PFE   52.43 (+2.93%)
PYPL   69.84 (-2.28%)
NFLX   174.87 (-1.96%)
NYSE:IQV

IQVIA Stock Forecast, Price & News

$216.99
+2.88 (+1.35%)
(As of 06/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$211.27
$220.28
50-Day Range
$196.45
$236.17
52-Week Range
$194.67
$285.61
Volume
1.80 million shs
Average Volume
1.16 million shs
Market Capitalization
$41.07 billion
P/E Ratio
39.10
Dividend Yield
N/A
Price Target
$277.80
30 days | 90 days | 365 days | Advanced Chart

Receive IQV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IQVIA and its competitors with MarketBeat's FREE daily newsletter.

IQV Stock Forecast (MarketRank)

Overall MarketRank

2.21 out of 5 stars

Business Services Sector

150th out of 467 stocks

Commercial Physical Research Industry

7th out of 24 stocks

Analyst Opinion: 3.5Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
IQVIA logo

About IQVIA (NYSE:IQV)

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

IQV Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Fax
N/A
Employees
79,000
Year Founded
2016

Company Calendar

Last Earnings
4/27/2022
Today
6/30/2022
Next Earnings (Estimated)
7/26/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$277.80
High Stock Price Forecast
$320.00
Low Stock Price Forecast
$235.00
Forecasted Upside/Downside
+28.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.94117647058824
Research Coverage
17 Analysts

Profitability

Net Income
$966 million
Pretax Margin
9.06%

Debt

Sales & Book Value

Annual Sales
$13.87 billion
Cash Flow
$15.44 per share
Book Value
$31.63 per share

Miscellaneous

Free Float
186,818,000
Market Cap
$41.07 billion
Optionable
Optionable
Beta
1.41

Social Links















IQVIA Frequently Asked Questions

Should I buy or sell IQVIA stock right now?

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IQVIA in the last year. There are currently 1 hold rating and 16 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" IQVIA stock.
View analyst ratings for IQVIA
or view top-rated stocks.

What is IQVIA's stock price forecast for 2022?

17 analysts have issued 12 month price targets for IQVIA's shares. Their IQV stock forecasts range from $235.00 to $320.00. On average, they expect IQVIA's stock price to reach $277.80 in the next twelve months. This suggests a possible upside of 28.0% from the stock's current price.
View analysts' price targets for IQVIA
or view top-rated stocks among Wall Street analysts.

How has IQVIA's stock performed in 2022?

IQVIA's stock was trading at $282.14 at the beginning of 2022. Since then, IQV stock has decreased by 23.1% and is now trading at $216.99.
View the best growth stocks for 2022 here
.

When is IQVIA's next earnings date?

IQVIA is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for IQVIA
.

How were IQVIA's earnings last quarter?

IQVIA Holdings Inc. (NYSE:IQV) released its earnings results on Wednesday, April, 27th. The medical research company reported $2.34 EPS for the quarter, beating analysts' consensus estimates of $2.27 by $0.07. The medical research company earned $3.57 billion during the quarter, compared to the consensus estimate of $3.54 billion. IQVIA had a trailing twelve-month return on equity of 28.80% and a net margin of 7.69%. The firm's revenue was up 4.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.05 EPS.
View IQVIA's earnings history
.

What guidance has IQVIA issued on next quarter's earnings?

IQVIA issued an update on its FY22 earnings guidance on Wednesday, April, 27th. The company provided earnings per share guidance of $9.95-10.25 for the period, compared to the consensus earnings per share estimate of $10.12. The company issued revenue guidance of $14.45-14.75 billion, compared to the consensus revenue estimate of $14.79 billion.

Who are IQVIA's key executives?

IQVIA's management team includes the following people:
  • Mr. Ari Bousbib, Chairman, Pres & CEO (Age 61, Pay $9.55M)
  • Mr. Ronald E. Bruehlman, Exec. VP & CFO (Age 61, Pay $2.67M) (LinkedIn Profile)
  • Mr. Kevin C. Knightly, Pres of Technology & Commercial Solutions (Age 61, Pay $1.45M)
  • Mr. Eric M. Sherbet, Exec. VP, Gen. Counsel & Sec. (Age 58, Pay $1.37M)
  • Mr. Emmanuel N. Korakis, Sr. VP, Corp. Controller, Chief Accounting Officer & Treasurer (Age 48)
  • Dr. Jeffrey A. Spaeder, Sr. VP, Global Chief Medical & Scientific Officer
  • Mr. Alejandro Martinez, Chief Information Officer
  • Andrew Markwick, Sr. VP of Investor Relations
  • Mr. Nicholas Childs, Sr. VP, Investor Relations & Corp. Communications
  • Ms. Trudy Stein, Chief HR Officer & Exec. VP

What is Ari Bousbib's approval rating as IQVIA's CEO?

1,545 employees have rated IQVIA CEO Ari Bousbib on Glassdoor.com. Ari Bousbib has an approval rating of 84% among IQVIA's employees.

What other stocks do shareholders of IQVIA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IQVIA investors own include CA (CA), BlackRock (BLK), NVIDIA (NVDA), Micron Technology (MU), Endologix (ELGX), Chipotle Mexican Grill (CMG), Alibaba Group (BABA), PayPal (PYPL), Salesforce (CRM) and Accenture (ACN).

What is IQVIA's stock symbol?

IQVIA trades on the New York Stock Exchange (NYSE) under the ticker symbol "IQV."

How do I buy shares of IQVIA?

Shares of IQV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IQVIA's stock price today?

One share of IQV stock can currently be purchased for approximately $216.99.

How much money does IQVIA make?

IQVIA (NYSE:IQV) has a market capitalization of $41.07 billion and generates $13.87 billion in revenue each year. The medical research company earns $966 million in net income (profit) each year or $5.55 on an earnings per share basis.

How many employees does IQVIA have?

IQVIA employs 79,000 workers across the globe.

Does IQVIA have any subsidiaries?

The following companies are subsidiares of IQVIA: 159 Solutions LLC, 159 Technology Solutions Private Ltd, AECIO IT Solutions India Private Ltd., ALIMED Egeszsegugyi Szolgaltato Kft., Advanced Health Media LLC, Advanced Health Media Services Ltd., Aileron Solutions, Albatross Financial Solutions Limited, Allcare Plus Pharmacy LLC, Aposphäre GmbH, Appature Inc., Ardentia International Limited, Ascott Sales Integration Pty Ltd, Asesorias IQVIA Solutions Chile Limitada, Asserta Centroamerica Medicion de Mercados S.A., Avacare Clinical Research Network (Shanghai) Co. Ltd., BUZZEOPDMA LLC, Battaerd Mansley (Proprietary) Limited, Battaerd Mansley Pty. Ltd., Benefit Holding Inc., Biofortis LLC, Branch of IQVIA RDS GesmbH in Novosibirsk, Branch of IQVIA RDS GesmbH in St. Petersburg, CDS - Centre de Service SAS, CFS Clinical UK Limited, CRM Health Korea Ltd., CSD Health Korea Ltd., CT Clinical Portugal Unipessoal Lda, CT Clinical Services Eood, CT Consulting Inc., Cambridge Pharma Consultancy Inc., Cambridge Pharma Consultancy Limited, Cegedim Venezuela C.A., Cenduit (India) Services Private Company Limited, Cenduit GmbH, Cenduit Holdings LLC, Cenduit LLC, Cenduit LLC Shanghai Rep. Office, Cenduit Limited, Cenduit Mauritius Holdings Company, Centrix Innovations (Pty) Ltd., ClinTec Austria GmbH, ClinTec CRO Services (India) Private Limited, ClinTec Gesellschaft fur Klinische Entwicklung GmbH, ClinTec International (Pty) Ltd., ClinTec International (Pty) Ltd. (Malawi branch), ClinTec International (Thailand) Limited, ClinTec International AG, ClinTec International Belgium BV, ClinTec International Bulgaria OOD, ClinTec International Co. Ltd., ClinTec International Denmark ApS, ClinTec International FZ-LLC, ClinTec International Hong Kong Limited, ClinTec International Hungary Kft, ClinTec International Italy S.r.l., ClinTec International LLC, ClinTec International Limited, ClinTec International Ltd (Netherlands Branch), ClinTec International Ltd UK Filial Sverige, ClinTec International Ltd., ClinTec International Norway AS, ClinTec International Off-Shore S.A.L., ClinTec International Pte Ltd., ClinTec International Pty Ltd, ClinTec International RUS LLC, ClinTec International Romania S.R.L., ClinTec International S.à r.l., ClinTec International SL, ClinTec International Services Inc., ClinTec International d.o.o. za trgov inuisludge, ClinTec International doo, ClinTec International s.r.o., ClinTec International sp. z.o.o., ClinTec Luxembourg S.A., ClinTec Turkey Medikal ve Farmasotik Hizmetler Ticaret Limited Sirketi, ClinTech Ireland International Research Limited, Clinical Financial Services LLC, Clinical Insourcing Solutions Limited, Clinical Insourcing Solutions S. de R.L. de C.V., Clinical Lab Minority Shareholder Limited, Clintec International Inc., Clintec International Pharmaceutical Services Ltd, Compliant Community Projects (Pty) Ltd., CoreZetta Co Ltd., Data Niche Associates Inc., Dataline Software Limited, Datandina Ecuador S.A., Datec Industria e Comercio Distribudora Grafica e Mala Direta Ltda., Dimensions Healthcare Company Ltd, Dimensions Healthcare LLC, Dimensions Healthcare LLC (Dubai Branch), DrugDev, DrugDev Inc., DrugDev Limited, EA Institute L.L.C., EPID Research Oy, EPID Research Sweden, EPS Research Limited, EPS Software Limited, Enterprise Associates L.L.C., Epernicus LLC, Excel Life Sciences Inc., Excel Life Sciences Pvt Ltd India, Forcea NV, Foresight IT Solutions and Consulting India Private Limited, GCE Clin Solutions Limited, GCE Global Solutions LLC, GCE Solutions GmbH, GCE Solutions International LLC, GCE Solutions Proprietary Limited, GCE Solutions S. de R.L. de C.V., Global Crown Investment Limited, Grace Data Corp., HighPoint Solutions LLC, Highpoint Solutions LLC (Geneva Branch), Hospital Marketing Services Ltd., Hotel Lot C-8B LLC, IMS (UK) Pension Plan Trustee Company Limited, IMS AB, IMS Government Solutions Inc., IMS HEALTH GROUP LIMITED, IMS HEALTH KOREA LTD., IMS Health (Australia) Partnership, IMS Health Analytics Services Private Limited, IMS Health Information Solutions Australia Pty. Ltd, IMS Health Information Solutions India Private Ltd., IMS Health Networks Limited, IMS Health Paraguay SRL, IMS Health Surveys Limited, IMS Health Uruguay S.A., IMS Health de Venezuela C.A., IMS Hospital Group Limited, IMS Information Solutions Medical Research Limited, IMS Information Solutions UK Ltd., IMS International (Proprietary) Limited, IMS Meridian Limited, IMS Meridian Research Limited, IMS SOFTWARE SERVICES LTD., IMS Technology Solutions UK Limited, INCARNUS MALAYSIA SDN BHD, IPP Informacion Promocional y Publicitaria S.A. de C.V., IQVIA (Thailand) Co. Ltd., IQVIA AB, IQVIA AG, IQVIA AG (Basal Branch), IQVIA AG (Dubai Branch), IQVIA AG (Mexico Branch), IQVIA AG (Representative Office - Algeria), IQVIA AG (Representative Office - Dubai), IQVIA AG (Representative Office - Jordan), IQVIA AG (Representative Office - Lebanon), IQVIA AG (Representative Office - Serbia), IQVIA AG (Rotkreuz Branch), IQVIA AG (UK Branch), IQVIA Adriatic d.o.o. za Konzalting, IQVIA Asia Pacific Commercial Holdings LLC, IQVIA Beteiligungsgesellschaft mbH, IQVIA BioSciences Holdings LLC, IQVIA Biotech LLC, IQVIA Biotech Ltd., IQVIA CHINAMETRIK INC., IQVIA COMMERCIAL FINANCE INC., IQVIA COMMERCIAL INDIA HOLDINGS CORP., IQVIA COMMERCIAL SERVICES LLC, IQVIA COMMERCIAL TRADING CORP., IQVIA CSMS GmbH, IQVIA CSMS US Inc., IQVIA Clinical AB, IQVIA Clinical Filial af IQVIA Clinical AB, IQVIA Commercial Consulting Sp. z.o.o., IQVIA Commercial Deutschland GmbH, IQVIA Commercial GmbH & Co. OHG, IQVIA Commercial I LLC, IQVIA Commercial Software GmbH, IQVIA Commercial Sp. z.o.o., IQVIA Consulting Solutions BV, IQVIA Consulting and Information Services India Private Limited, IQVIA FZ-LLC, IQVIA Finance Ireland Designated Activity Company, IQVIA GOVERNMENT SOLUTIONS INC., IQVIA Healthcare (QFC Branch), IQVIA Hellas Technology Solutions Single Member S.A., IQVIA Holdings (UK) Ltd., IQVIA Holdings France SAS, IQVIA IES Brasil Ltda., IQVIA IES Denmark ApS, IQVIA IES Europe Limited, IQVIA IES European Holdings, IQVIA IES Italia S.r.l., IQVIA IES OY, IQVIA IES Overseas Holdings Limited, IQVIA IES Portugal Unipessoal LDA, IQVIA IES Puerto Rico Inc., IQVIA IES South Africa (Pty) Limited, IQVIA IES UK Limited, IQVIA II Technology Solutions Portugal Unipessoal LDA, IQVIA INC., IQVIA INFORMATION MEDICAL STATISTICS (ISRAEL) LTD., IQVIA Inc. (Thailand Branch), IQVIA Information S.A., IQVIA Information Solutions (China) Co. Ltd., IQVIA Information Solutions GmbH, IQVIA Integrated Services NL, IQVIA Investment Holdings Limited, IQVIA Korea Co. Ltd., IQVIA LTD., IQVIA Lebanon S.a.r.l., IQVIA Market Intelligence LLC, IQVIA Marktforschung GmbH, IQVIA Maroc S.à r.l., IQVIA MedTech Inc., IQVIA MedTech NV, IQVIA Medical Communications & Consulting Inc., IQVIA Medical Development (Dalian) Co. Ltd., IQVIA Medical Education Inc., IQVIA Medical Radar AB, IQVIA Operations France SAS, IQVIA PHARMA Inc., IQVIA Partners AS, IQVIA Pharma Services Corp., IQVIA Pharmaceutical Marketing Services Ltd., IQVIA Phase One Services LLC, IQVIA RDS (India) Private Ltd., IQVIA RDS (Pty.) Limited, IQVIA RDS (Shanghai) Co. Ltd., IQVIA RDS AG, IQVIA RDS Argentina S.R.L., IQVIA RDS Asia Inc., IQVIA RDS Austria GmbH, IQVIA RDS BT Inc., IQVIA RDS Brasil Ltda., IQVIA RDS Bulgaria EOOD, IQVIA RDS Canada ULC, IQVIA RDS Chile, IQVIA RDS Clindata (Pty.) Ltd., IQVIA RDS Clindepharm (Pty.) Ltd., IQVIA RDS Colombia S.A.S., IQVIA RDS Costa Rica S.A., IQVIA RDS Czech Republic s.r.o., IQVIA RDS ESTONIA OU, IQVIA RDS East Asia Pte. Ltd., IQVIA RDS Eastern Holdings GmbH, IQVIA RDS Egypt LLC, IQVIA RDS Finland OY, IQVIA RDS France SAS, IQVIA RDS Funding LLC, IQVIA RDS GesmbH, IQVIA RDS GmbH, IQVIA RDS Guatemala S.A., IQVIA RDS Hellas Single Member S.A., IQVIA RDS Holdings, IQVIA RDS Hong Kong Limited, IQVIA RDS Hungary Pharmaceutical Development and Consulting Limited Liability Company, IQVIA RDS ISRAEL LTD., IQVIA RDS Inc., IQVIA RDS Ireland (Finance) Ltd., IQVIA RDS Ireland Ltd., IQVIA RDS Italy S.r.l., IQVIA RDS Latin America LLC, IQVIA RDS Latin America LLC (Argentina Branch), IQVIA RDS Latvia SIA, IQVIA RDS Malaysia Sdn. Bhd., IQVIA RDS Netherlands B.V., IQVIA RDS Norway, IQVIA RDS Panama Inc., IQVIA RDS Peru S.r.l., IQVIA RDS Philippines Inc., IQVIA RDS Poland Sp. Zoo, IQVIA RDS Pty. Limited, IQVIA RDS Pty. Ltd., IQVIA RDS Slovakia s.r.o., IQVIA RDS South Africa (Pty.) Ltd., IQVIA RDS Spain S.L., IQVIA RDS Spain S.L. - Representação Permanente em Portugal, IQVIA RDS Switzerland S.à r.l., IQVIA RDS Taiwan Ltd., IQVIA RDS UAB, IQVIA RDS UK Holdings Ltd., IQVIA RDS Ukraine, IQVIA RDS Vietnam LLC, IQVIA RDS and Integrated Services Belgium NV, IQVIA RDS d.o.o. Beograd, IQVIA Research and Development Solutions Saudi Arabia Limited, IQVIA Romania S.R.L., IQVIA SOLUTIONS CANADA INC, IQVIA SOLUTIONS JAPAN K.K., IQVIA Services Japan K.K., IQVIA Solutions (NZ) Limited, IQVIA Solutions (Pty.) Ltd., IQVIA Solutions Argentina S.A., IQVIA Solutions Asia Pte. Ltd, IQVIA Solutions Australia Holdings Pty. Ltd., IQVIA Solutions Australia Pty. Ltd., IQVIA Solutions B.V., IQVIA Solutions Bangladesh Limited, IQVIA Solutions Belgium BV, IQVIA Solutions Bolivia S.R.L., IQVIA Solutions Bulgaria EOOD, IQVIA Solutions Colombia S.A., IQVIA Solutions Consulting Myanmar Company Limited, IQVIA Solutions Denmark AS, IQVIA Solutions Egypt Ltd., IQVIA Solutions Enterprise Management Consulting (Shanghai) Co. Ltd (Beijing Branch), IQVIA Solutions Enterprise Management Consulting (Shanghai) Co. Ltd., IQVIA Solutions Finance B.V., IQVIA Solutions Finance UK I Ltd., IQVIA Solutions Finance UK II Ltd., IQVIA Solutions Finance UK III Ltd., IQVIA Solutions Finance UK V Ltd., IQVIA Solutions Finland OY, IQVIA Solutions Global Holdings UK Ltd., IQVIA Solutions HQ Ltd., IQVIA Solutions Holdings (Pty.) Ltd., IQVIA Solutions Hong Kong Limited, IQVIA Solutions Ireland Limited, IQVIA Solutions Italy S.r.l., IQVIA Solutions Kazakhstan LLC, IQVIA Solutions LLC, IQVIA Solutions Lanka (Private) Limited, IQVIA Solutions Malaysia Sdn. Bhd., IQVIA Solutions Norway AS, IQVIA Solutions Operations Center Philippines Inc., IQVIA Solutions Pakistan (Private) Limited, IQVIA Solutions Pharmaceutical SRL, IQVIA Solutions Philippines Inc., IQVIA Solutions Portugal Lda, IQVIA Solutions Puerto Rico Inc., IQVIA Solutions Regional Pte. Ltd., IQVIA Solutions Republica Dominicana S.R.L., IQVIA Solutions Saudi Arabia Limited, IQVIA Solutions Services Ltd., IQVIA Solutions Sweden AB, IQVIA Solutions Tunisia S.à r.l., IQVIA Solutions UK Investments Ltd., IQVIA Solutions UK Limited, IQVIA Solutions a.s., IQVIA Solutions del Peru S.A., IQVIA Solutions do Brasil Ltda., IQVIA Solutions s.r.o., IQVIA Soluções de Tecnologia do Brasil Ltda, IQVIA Staff Services Sp.A., IQVIA TRANSPORTATION SERVICES CORP., IQVIA Technology Services Ltd., IQVIA Technology Solutions (China) Co. Ltd., IQVIA Technology Solutions Colombia Ltda., IQVIA Technology Solutions Egypt LLC, IQVIA Technology Solutions Finland OY, IQVIA Technology Solutions Poland SP. z.o.o, IQVIA Technology Solutions Romania Srl, IQVIA Technology Solutions S.R.O. (Bulgaria Branch), IQVIA Technology Solutions Ukraine LLC, IQVIA Technology Solutions s.r.o., IQVIA Technology Tunisia S.à r.l., IQVIA Tibbi Istatistik Ticaret ve Musavirlik Ltd. Sirketi, IQVIA Trading Management Inc., IQVIA World Publications Ltd., IQVIA Zagreb d.o.o., Iasist Holdco Limited, Iasist Portugal Consultadoria na Área de Saúde Unipessoal Lda, Iasist SAU Agencia en Chile, Iasist Sociedad Anonima Unipersonal, Impact RX Data Management (Pty) Ltd., Infocus Health Limited, Infopharm Ltd., Innovex Holdings I LLC, Innovex Merger Corp., Innovex Saglik Urunleri Pazarlame ve Hizmet Danismanlik Anonim Sirketi, Intercontinental Medical Statistics International Ltd., Intercontinental Medical Statistics Kenya Ltd., Interface Clinical Services Ltd., Interstatistik AG, Iqvia Solutions Taiwan Ltd., Jäger Health Gmbh, Kun Tai Medical Development Hong Kong Limited, Kun Tuo Medical Research & Development (Beijing) Co. Ltd., Laboratorio Commuq Pharma SLU, Linguamatics, Linguamatics Limited, Linguamatics Solutions Limited, M&H Informatics (BD) LTD., Mecurial Insights Holding Pty. Ltd., Mecurial Insights Pty. Ltd., Med-Vantage Inc., Meddata Group LLC, MedicSense Ltd., Medineos S.r.l., Mercados Y Analisis S.A., Meridian Research Vietnam Ltd., Novasyte LLC, Novella Clinical LLC, Novex Pharma Laboratorio S.L., Novex Pharma Limited, Nuevo Health Pty Ltd, Operaciones Centralizadas Latinoamericana Limitada, Optimum Contact Limited, Outcome Sciences LLC, PR Editions S.A.S., PT IQVIA RDS Indonesia, PT IQVIA Solutions Indonesia, Penderwood Limited, PharmARC Consulting Services GmbH, PharmARC Inc., Pharma Deals Limited, Pharma Strategy Group Limited, Pharmadata s.r.o., Pharmaforce S.A. de C.V., Polaris Management Partners LLC, Polaris Solutions LLC, Polaris Solutions Ltd., Privacy Analytics Inc., Professional Pharmaceutical Marketing Services (Pty.) Ltd., Prometheus Research LLC, Public Relations Algeria, Q Squared Solutions (Beijing) Co. Ltd., Q Squared Solutions (India) Private Limited, Q Squared Solutions (Quest) LLC, Q Squared Solutions (Quest) Limited, Q Squared Solutions (Shanghai) Co. Ltd., Q Squared Solutions B.V., Q Squared Solutions BioSciences LLC, Q Squared Solutions China (Quest) Limited, Q Squared Solutions China Limited, Q Squared Solutions Expression Analysis LLC, Q Squared Solutions Holdings B.V., Q Squared Solutions Holdings LLC, Q Squared Solutions Holdings Limited, Q Squared Solutions KK, Q Squared Solutions LLC, Q Squared Solutions Limited, Q Squared Solutions Proprietary Limited, Q Squared Solutions Pte. Ltd., Q Squared Solutions S.A., Q2 Solutions, QH Research Limited, QIMS Pharma Services SA DE CV, Qcare Site Services Inc., Quality Health Limited, Quintiles Benin Ltd., Quintiles Clinical and Commercial Nigeria Limited, Quintiles Commercial Laboratorio S.L.U., Quintiles Commercial Rus LLC, Quintiles East Africa Limited, Quintiles Finance Uruguay S.r.L., Quintiles IMS Japan GK, Quintiles Lanka (Private) Limited, Quintiles Mauritius Holdings, Quintiles Medical Development (Shanghai) Co. Ltd., Quintiles Mexico S. de R.L. de C.V., Quintiles New Zealand, Quintiles Phase One Clinical Trials India Private Limited, Quintiles RDS Latin America LLC, Quintiles Site Services S.A., Quintiles West Africa Limited, RX India LLC, Radar Acquisition Blocker Inc., Redsite Limited, Representative Office of IQVIA RDS GesmbH in Moscow, STI Technologies Limited, Schwarzeck Verlag GmbH, Secureconsent LLC, Shanghai IMS Market Research Co. Ltd., Smart I.T. Systems BV, Source Informatics Limited, Spartan Leasing Corporation, StatFin Estonia, Statfinn Oy, Targeted Molecular Diagnostics LLC, Tarius A/S, Temas Srl - Società Unipersonale, TforG Support NV, The Amundsen Group Inc., Themis Limited, UAB IQVIA Commercial, VCG&A Inc., VCG-BIO Inc., Valuecentric Global Services Gmbh, Valuecentric Privacy Solutions LLC, Valuemedics Research LLC, Vivacity Health Pty. Ltd., genae Germany Gmbh, genae International Ag, and iGuard Inc..
Read More

When was IQVIA founded?

IQVIA was founded in 2016.

How can I contact IQVIA?

IQVIA's mailing address is 4820 EMPEROR BOULEVARD, DURHAM NC, 27703. The official website for IQVIA is www.iqvia.com. The medical research company can be reached via phone at (919) 998-2000 or via email at [email protected].

This page (NYSE:IQV) was last updated on 6/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.